ROYCE LABORATORIES PUBLIC OFFERING DECLARED EFFECTIVE
ROYCE LABORATORIES PUBLIC OFFERING DECLARED EFFECTIVE MIAMI, Jan. 9 /PRNewswire/ -- Royce Laboratories, Inc.
(NASDAQ: RLAB) announced today that its Registration Statement on Form S-1 (SEC File No. 33-43890) was declared effective by the U.S. Securities and Exchange Commission as of 10:15 a.m. EST today.
The Registration Statement registers, among other securities, 1 million units of the company's securities, each unit consisting of two shares of common stock and one warrant to purchase one-half share of common stock at a purchase price of $10.00 per share. The units were priced at $6.00 each, and were sold by the company on a firm commitment basis to the underwriters of the public offering, Paradise Valley Securities, Inc., Chatfield Dean & Co., Inc. and First American Biltmore Securities, Inc. The public offering is expected to close Jan. 16, 1992. Royce Laboratories, Inc. is a manufacturer of prescription and over the counter generic pharmaceuticals. -0- 1/9/92 /CONTACT: Patrick J. McEnany, president of Royce Laboratories, Inc., 305-624-1500/ (RLAB) CO: Royce Laboratories, Inc. ST: Florida IN: MTC SU: OFR
AW-SS -- FL013 -- 8328 01/09/92 15:12 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 9, 1992|
|Previous Article:||CHEMICAL BANKING $4.1 BILLION SENIOR DEBT TO BE RATED 'A' BY FITCH -- FITCH FINANCIAL WIRE --|
|Next Article:||MINERALS MANAGEMENT SERVICE ANNOUNCES REPORT ON THE CAROLINA TROUGH|